These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16055748)

  • 1. New methods to evaluate colocalization of fluorophores in immunocytochemical preparations as exemplified by a study on A2A and D2 receptors in Chinese hamster ovary cells.
    Agnati LF; Fuxe K; Torvinen M; Genedani S; Franco R; Watson S; Nussdorfer GG; Leo G; Guidolin D
    J Histochem Cytochem; 2005 Aug; 53(8):941-53. PubMed ID: 16055748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2A-dopamine D2 receptor heterodimers.
    Genedani S; Guidolin D; Leo G; Filaferro M; Torvinen M; Woods AS; Fuxe K; Ferré S; Agnati LF
    J Mol Neurosci; 2005; 26(2-3):177-84. PubMed ID: 16012191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-dependent internalization of D2 receptors: Imaging quantification by confocal microscopy.
    Goggi JL; Sardini A; Egerton A; Strange PG; Grasby PM
    Synapse; 2007 Apr; 61(4):231-41. PubMed ID: 17230553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission.
    Tozzi A; Tscherter A; Belcastro V; Tantucci M; Costa C; Picconi B; Centonze D; Calabresi P; Borsini F
    Neuropharmacology; 2007 Nov; 53(6):783-9. PubMed ID: 17889039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications.
    Morelli M; Di Paolo T; Wardas J; Calon F; Xiao D; Schwarzschild MA
    Prog Neurobiol; 2007 Dec; 83(5):293-309. PubMed ID: 17826884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D2 receptors.
    Jordan S; Chen R; Fernalld R; Johnson J; Regardie K; Kambayashi J; Tadori Y; Kitagawa H; Kikuchi T
    Eur J Pharmacol; 2006 Jul; 540(1-3):53-6. PubMed ID: 16730695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry application for studies on adenosine A2A receptors expression.
    Wójcik T; Bereta M; Faron-Górecka A; Dziedzicka-Wasylewska M; Kieć-Kononowicz K
    Acta Pol Pharm; 2008; 65(1):65-70. PubMed ID: 18536175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine agonist action at dopamine D2High receptors.
    Seeman P; Caruso C; Lasaga M
    Synapse; 2008 Feb; 62(2):149-53. PubMed ID: 18000814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A(2A) receptor agonist and adenosine A(3) receptor antagonist activity.
    Bevan N; Butchers PR; Cousins R; Coates J; Edgar EV; Morrison V; Sheehan MJ; Reeves J; Wilson DJ
    Eur J Pharmacol; 2007 Jun; 564(1-3):219-25. PubMed ID: 17382926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
    Lambertucci C; Antonini I; Buccioni M; Dal Ben D; Kachare DD; Volpini R; Klotz KN; Cristalli G
    Bioorg Med Chem; 2009 Apr; 17(7):2812-22. PubMed ID: 19282184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells.
    Middleton RJ; Briddon SJ; Cordeaux Y; Yates AS; Dale CL; George MW; Baker JG; Hill SJ; Kellam B
    J Med Chem; 2007 Feb; 50(4):782-93. PubMed ID: 17249651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoloquinolizidine-peptide hybrids as multiple agonists for D1 and D2 dopamine receptors.
    Vendrell M; Soriano A; Casadó V; Díaz JL; Lavilla R; Canela EI; Lluís C; Franco R; Albericio F; Royo M
    ChemMedChem; 2009 Sep; 4(9):1514-22. PubMed ID: 19557804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
    Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between cell cycle phase of adherent Chinese hamster ovary cells and laser phase shift determined by phase-shifting laser microscopy.
    Ito S; Takagi M
    Biotechnol Lett; 2009 Jan; 31(1):39-42. PubMed ID: 18850071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells.
    Vidi PA; Chemel BR; Hu CD; Watts VJ
    Mol Pharmacol; 2008 Sep; 74(3):544-51. PubMed ID: 18524886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A2A adenosine-receptor-mediated facilitation of noradrenaline release in rat tail artery involves protein kinase C activation and betagamma subunits formed after alpha2-adrenoceptor activation.
    Fresco P; Oliveira JM; Kunc F; Soares AS; Rocha-Pereira C; Gonçalves J; Diniz C
    Neurochem Int; 2007 Jul; 51(1):47-56. PubMed ID: 17493708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors.
    Yu N; Atienza JM; Bernard J; Blanc S; Zhu J; Wang X; Xu X; Abassi YA
    Anal Chem; 2006 Jan; 78(1):35-43. PubMed ID: 16383308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of immunofluorescent punctate staining of synaptically localized proteins using confocal microscopy and stereology.
    Mokin M; Keifer J
    J Neurosci Methods; 2006 Oct; 157(2):218-24. PubMed ID: 16740315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonist-radioligand binding to D2L-receptors in intact cells.
    Packeu A; De Backer JP; Van Liefde I; Vanderheyden PM; Vauquelin G
    Biochem Pharmacol; 2008 Jun; 75(11):2192-203. PubMed ID: 18436192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
    Mihara T; Mihara K; Yarimizu J; Mitani Y; Matsuda R; Yamamoto H; Aoki S; Akahane A; Iwashita A; Matsuoka N
    J Pharmacol Exp Ther; 2007 Nov; 323(2):708-19. PubMed ID: 17684118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.